{"id":"W2127254785","doi":"10.1016/s0140-6736(03)14285-7","title":"Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial","year":2003,"lang":"en","type":"article","venue":"The Lancet","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":2984,"is_retracted":false,"has_abstract":false,"ca_institutions":"Hamilton General Hospital","funders":"AstraZeneca","keywords":"Candesartan; Ejection fraction; Medicine; Heart failure; Cardiology; Internal medicine; Hazard ratio; Placebo; Myocardial infarction; Stroke (engine); Angiotensin II; ACE inhibitor; Angiotensin-converting enzyme; Confidence interval; Blood pressure","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null}